Skip to content

Patients › Hand

扳机指

Trigger finger causes painful catching or locking of a finger, often treated with splinting or steroid injection.

Updated Oct 2026
一幅手绘插图,展示了一只手,其中一根手指卡住呈弯曲状态,在伸直时发生卡顿。
扳机指:手指弯曲时出现卡顿或锁定。 Kieran Hirpara 4.0

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

您的感受

扳机指影响的是弯曲手指或拇指的肌腱。这些肌腱在手掌中一条称为滑车的狭窄隧道中滑动。当肌腱增厚时,它在穿过该隧道时会被卡住。您会感到手掌疼痛和压痛,位置在受累手指或拇指的基部。有些人会在该处的手掌中摸到一个小肿块或结节。这个肿块是肌腱或其隧道增厚的部分,它会随着肌腱的移动而移动。

卡顿起初通常只是轻微的困扰,并在数周内逐渐加重。早期,您的手指在弯曲和伸直时可能会出现弹响或卡顿,您可能需要用另一只手将其伸直。随着病情加重,手指可能会锁定在弯曲位置并一直保持这样。许多人发现醒来时最僵硬,白天活动后手指会逐渐松开。抓握和捏夹动作会加重症状,因此握方向盘、提购物袋、使用剪刀或握住瓶罐盖子等任务可能会变得不适。有些人还会感到同一手指的指关节背面或中间关节酸痛,尽管问题出在手掌。

扳机指很常见。它影响 2% 至 3% 的人,女性比男性更常见,通常在 45 岁以后出现。如果不止一根手指出现扳机现象,值得告知您的外科医生,因为这可能与糖尿病等其他疾病有关。扳机指也常与腕管综合征同时出现,后者会导致手部刺痛或麻木,两者在 40% 至 60% 的扳机指患者中同时发生。

如果您的症状没有缓解、在数周内逐渐加重、在夜间使您醒来,或使您无法工作或使用手部,请咨询您的全科医生或要求专科医生评估。

实际发生了什么

弯曲手指的肌腱就像穿过手掌和手指中一组引导环的绳索。其中第一个环位于手掌内的手指基部,称为 A1 滑车。当您反复抓握或挤压时,肌腱在穿过该环的部位可能会受到刺激。受刺激的部位会增厚,因此绳索不再能顺畅滑动,而是会堆积起来,然后硬挤过变窄的环,这就是您感觉到的卡顿或弹响。

肌腱上增厚的部位通常是一个小结节,即一团发生改变的组织,比绳索其余部分稍宽。每次弯曲手指时,这个结都必须从滑车下方挤过。它会伴随咔哒一声滑过去,然后在您试图伸直时卡在另一侧。这就是为什么手指可能锁定在弯曲状态、需要用另一只手才能松开;也是为什么经过一夜手指保持弯曲休息后,问题在早晨感觉最严重。

医生将病情进展程度分为四个阶段。第一阶段是第一个环所在的手掌处疼痛和压痛。第二阶段在此基础上出现手指卡顿。第三阶段是手指锁定,但您仍可以用另一只手推动将其伸直。第四阶段是手指卡在弯曲状态,完全无法再伸直。较早的阶段通常可以通过较简单的治疗得到缓解,而已经锁定的手指通常需要一个小手术来打开滑车,使肌腱能够再次滑动。

有几种因素使这种增厚更容易发生。反复用力抓握是原因之一,这就是为什么它在赛艇运动员以及其他抓握负荷较重的人中很常见。它还与糖尿病、甲状腺功能减退、痛风和类风湿关节炎等疾病有关,在这些疾病中,肌腱周围的组织会发生炎症或改变,从而使隧道变窄。如果多根手指同时出现扳机现象,这种模式值得指出,因为它可能提示存在上述某种潜在疾病。

我们如何处理该问题

Mater Private Hospital Rockhampton 的上肢外科医生 Kieran Hirpara 医生会从适合您病情的最微创方案开始。患者通常由其全科医生(GP)转诊至我们的诊所;如果理疗师建议您就诊,您仍需获得全科医生的转诊才能符合 Medicare 报销资格。就诊时,我们会采集病史,检查您的手部,并仅在影像学检查会改变治疗方案时才安排该检查。对于这类长期存在的问题,我们通常先尝试非手术治疗,在其未能带来足够改善时再考虑手术。

第一步是让您的手部平静下来。改变您抓握的方式,减少对手掌造成负荷的任务(例如提重物或用力挤压),可以让受刺激的肌腱有机会恢复平静。手部治疗旨在恢复肌腱在滑车中的顺畅滑动,并保持手指关节的活动。保持手指静止的夹板可以是其中的一部分,而且佩戴足够长的时间效果最好:证据支持的时长是将单个关节固定 6 至 10 周,这比大多数人预想的要长。在评判这些措施的效果之前,请给它们数周的充分尝试。

如果简单措施未能缓解症状,下一步通常是向肌腱隧道内注射可的松。可的松可以减轻导致肌腱卡住的肿胀和增厚。糖尿病患者对可的松注射的反应往往较差,在选择方案时值得了解这一点。大多数人预想注射会比实际更痛,事后表示比他们预先做好心理准备的要轻松。

当手指持续锁定,或注射和夹板固定未能带来足够改善时,就需要考虑手术。手术会松解手指基部紧缩的滑车,使肌腱能够再次自由滑动。手术通过手掌上的一个小切口进行,是一种简单、成熟的手术。我们将与您讨论它是否适合您,并共同做出决定。术后,您的康复是由 Extend Rehabilitation 的 Ruby Doolan 提供的手部治疗;她会指导您的锻炼,并为您制作所需的任何夹板。

预期情况

一旦手指出现卡顿或锁定,扳机指很少会自行恢复正常。早期,当只有手掌疼痛和压痛时,改变抓握方式、手部治疗和夹板等较简单的治疗可以使症状缓解。夹板需要佩戴足够长的时间才能起效:对于单个关节,证据支持的时长为 6 至 10 周。如果这些措施没有帮助,向肌腱隧道内注射可的松可使略多于一半的人问题得到缓解,因此第二次注射或转为手术是正常的下一步,而不是意味着出了问题。

当手指已发展到锁定阶段时,松解紧缩的滑车是针对病因的治疗。之后肌腱能够再次在隧道中滑动,术后鼓励您正常使用手指或拇指。大多数人都庆幸自己接受了手术。尽管如此,坦诚地了解一些细节也很重要。约 1/20 的手指术后会出现轻微、短暂的问题,最常见的是伤口周围疼痛、僵硬或肿胀。约 8.6% 的人会出现持续性僵硬,1.2% 的人会出现伤口延迟愈合。神经损伤或深部感染等严重问题并不常见:神经损伤或持久麻木的发生率为 0.6%,手术部位感染的发生率为 2.1%。约 1/200 的手指需要第二次手术,扳机症状复发的比例为 2.2%。

有几个因素会影响您的预后。如果手指的中间关节在治疗前已长期酸痛,即使松解了滑车,该关节的疼痛也可能无法完全消退。一次松解多根手指,往往比只松解一根手指术后疼痛和僵硬更明显。此外,在可的松注射后一个月内接受手术的人,术后伤口感染的几率更高,在安排手术时间时值得考虑这一点。

如果您的手指变得发热、发红、肿胀并疼痛,尤其是伴有发烧时,请当天前往急诊科。如果您的症状没有缓解、在数周内逐渐加重、在夜间使您醒来,或使您无法工作或使用手部,请咨询您的全科医生或要求专科医生评估。

何时就医

如果您的手指或拇指出现卡顿、锁定在弯曲状态,或需要用另一只手才能伸直,请咨询您的全科医生或要求专科医生评估。如果您的手掌中有一个随肌腱移动的压痛肿块,或者卡顿使您无法抓握、工作或睡眠,也同样适用。如果不止一根手指出现扳机现象,也请告知医生,因为这可能提示存在糖尿病等潜在疾病。这一点在儿童中更为重要:如果孩子不止一个手指或拇指出现扳机现象,或扳机现象伴有刺痛或麻木,需要专科医生评估,而不是采取观察等待的做法。如果您的手指变得发热、发红、肿胀并疼痛,尤其是伴有发烧时,或者您的手指变得苍白、冰冷、发白或发青,请当天前往急诊科。

深入探讨

Advanced reading: the deeper science (optional)

本节内容超出了您自身治疗决策所需的范围。扳机指值得额外阅读,因为一线治疗的成功率仅略高于一半,而这一数据很少被引用;此外,在儿童中,相同的临床表现意味着不同的情况,足以改变检查方案。

注射有效,且真实数据为57%

皮质类固醇注射是标准的一线干预措施,通常被简单描述为有效。I级和II级研究的汇总数据更为具体:皮质类固醇注射对57%的扳机指患者有效。尽管所纳入的研究存在局限性,但基于其简便性及症状缓解效果,它仍被推荐作为一线治疗 [1]。

在接受注射前了解57%这一数据至关重要。它将第二次注射或决定进行手术重新定义为相当一部分患者的预期路径,而非意味着出现了问题。

夹板固定是一种切实可行的替代方案,且其持续时间通常长于多数人的预期

在注射治疗不适用时(例如在糖尿病患者中,注射可能干扰血糖控制),矫形器管理具有合理的循证依据。各项研究的一致发现是,无论固定哪个关节,疗效均相似,并建议将单个关节固定6至10周 [2]。

这一持续时间正是人们容易低估的部分。仅佩戴两周的夹板并不能作为夹板固定疗效的试验。

手术松解:技术之争已定,入路问题未决

A1滑车松解可采用开放手术(经小切口直视下操作)或经皮穿刺(使用针或刀片)进行。汇总548例患者的数据显示,开放技术与经皮技术在翻修需求、并发症或术后疼痛方面无显著差异,因此两者均适用 [3]。

一项涵盖2,114个手指的经皮松解大型分析发现该技术有效且安全,并补充了两个有用的细节:超声引导可能提高成功率,而成功率不受所用器械或是否联合使用皮质类固醇的影响 [4]。2025年一项针对685例患者的综述发现,将经皮松解与皮质类固醇注射联合应用耐受性良好,并发症发生率低 [5]。

综上所述:滑车需要被切断,如何实现这一目标的重要性低于是否完全实现。器械并不决定结果。

在儿童中,相同的发现需要不同的应对

儿童扳机指并非成人疾病提前出现。若存在双侧或多指扳机指,或并发腕管综合征,应警惕黏多糖贮积症等非典型潜在病理 [6]。

这是本节中临床意义最重大的要点。若儿童出现多指扳机指,或扳机指伴神经症状,应进行系统性贮积症的相关检查,而非直接行松解术,因为手部表现可能是某种诊断的首发体征,其影响远超手部本身。而在其他方面健康的儿童中,单个拇指出现扳机指是另一种情况,且远为常见。

参考文献

[1] Fleisch SB, Spindler KP, Lee DH. 皮质类固醇注射治疗扳机指:I级和II级系统评价。J Am Acad Orthop Surg. 2007;15(3):166-71. https://doi.org/10.5435/00124635-200703000-00006

[2] Lunsford D, Valdes K, Hengy S. 扳机指的保守治疗:系统评价。J Hand Ther. 2019;32(2):212-21. https://doi.org/10.1016/j.jht.2017.10.016

[3] Casey JC, Daher M, Dworkin M, Cusano J, Garavito J, Gil JA. 扳机指开放手术与经皮固定术:临床结局荟萃分析。J Hand Surg Am. 2024;49(6):570-5. https://doi.org/10.1016/j.jhsa.2024.03.010

[4] Zhao J, Kan S, Zhao L, Wang Z, Long L, Wang J, et al. 经皮第一环状滑车松解术治疗扳机指:当前证据的系统评价和荟萃分析。J Hand Surg Am. 2014;39(11):2192-202. https://doi.org/10.1016/j.jhsa.2014.07.044

[5] Wen J, Syed B, Khalil R, Shehabat M, Alam M, Sedighi R, et al. 经皮A1滑车联合皮质类固醇注射治疗扳机指:系统评价和荟萃分析。J Orthop Surg Res. 2025;20(1). https://doi.org/10.1186/s13018-025-05776-2

[6] Wong AL, Wong MJ, Parker R, Wheelock ME. 儿童扳机指的临床表现与病因:系统评价。J Hand Surg Eur Vol. 2021;47(2):192-6. https://doi.org/10.1177/17531934211035642


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

Non-Operative Management

  • Female patients presenting with their first trigger finger have the highest rate of long-term treatment success after a single corticosteroid injection [1].
  • Factors associated with a worse outcome following a steroid injection were identified and should be considered when choosing the treatment of a trigger finger [4].
  • Surgical management may be the next best option in patients with trigger finger who continue to be symptomatic after a single injection [12].
  • Management of trigger finger with 2 steroid injections before surgery is the least costly treatment strategy [14].
  • Repeated corticosteroid injections for recurrent trigger finger should be considered in patients who prefer nonsurgical treatment, especially in those without factors predictive of failure [33].
  • Offering up to three corticosteroid injections before surgical release represents the most cost-effective contemporary strategy for trigger finger management from a current Medicare payer perspective [62].
  • A referenced trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments [60].
  • The authors of the referenced trial recommend splinting alone as the least invasive option for the treatment of adults with trigger finger [60].

Operative Management

  • Open trigger finger release is generally a low-risk procedure, although there is potential for complications, some requiring reoperation [2].
  • Percutaneous release of the trigger finger should be the treatment of choice for the established trigger finger with symptoms of more than 4 months' duration [3].
  • Surgical open release is the “gold standard” of trigger finger treatment because it allows more careful inspection of the surgical area and is highly effective with low complication rates [5].
  • Percutaneous trigger finger release can safely be performed on all digits, including the thumb, small fingers, and index fingers [13].
  • The study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography [15].
  • Surgical release can be recommended as an adequate treatment with minimal morbidity for any grade of trigger finger or thumb with failed non-operative treatment and for severe (Grade IV) trigger digits [16].
  • Patients who undergo open trigger finger release surgery in the clinic have complication rates similar to reported complication rates of surgery performed in the operating room [17].
  • Percutaneous release is permanent, safe, and cost-effective and should be considered as first-line treatment for demonstrable trigger fingers [18].
  • The authors recommend open surgery for trigger finger and trigger thumb, citing excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing [49].
  • Procedure room-based treatment of trigger finger is less costly than release in the operating room [73].
  • The percutaneous technique using a L15 blade is recommended for trigger finger release because of lower costs and quicker procedure with equal functional outcome when compared with open surgery [97].

Surgical Technique

  • Local anesthetic infiltration in the palm proximal to the incision site is preferred for trigger finger release [20].
  • A transverse incision about 2 cm long several millimeters distal to the distal palmar crease is used for middle, ring, and small trigger finger releases [20].
  • A transverse incision about 2 cm long several millimeters distal to the proximal palmar crease is used for index trigger finger releases [20].
  • Trigger thumb releases can be done through incisions either distal or proximal to the metacarpophalangeal joint flexion crease [20].
  • The digital nerves on the thumb are more palmar and closer to the flexor sheath than might be anticipated, with the thumb radial digital nerve being especially vulnerable [20].
  • Trigger thumbs require release of only the A1 pulley, whereas trigger digits require division of the A1 and A0, or proximal palmar pulley [20].
  • For trigger thumb release, the surgeon should avoid cutting too far distally and disrupting the oblique pulley [20].
  • The tendon sheath is incised from proximal to distal, approximately 1 cm, and reassessed for triggering [20].
  • Persistent triggering after initial release implies that either the A1 and palmar pulleys are incompletely released or an alternate site of triggering is present [20].
  • When the distal A1 pulley edge is released, the divided pulley leaves are parallel rather than ending in a V-shaped pattern [20].
  • The compression dressing is removed after 48 hours and sutures are removed at 10 to 14 days postoperatively [20].
  • Normal use of the finger or thumb is encouraged after trigger finger release surgery [20].

Patient Preferences and Outcomes

  • Patients' preferences for trigger finger treatment often change after consulting with a hand surgeon and during treatment, but these choices do not affect treatment satisfaction [9].
  • Comparing patients and hand surgeons, there were some differences in treatment preferences and perceived advantages and disadvantages regarding idiopathic trigger finger [44].
  • These differences in treatment preferences between patients and hand surgeons might be addressed by a decision aid [44].

Safety and Complications

  • Ultrasound-assisted percutaneous trigger finger release raises questions regarding the safety and efficacy of the procedure, even when adding ultrasound guidance [7].
  • Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need ulnar superficialis slip resection during trigger finger release [34].
  • Patients who are more likely to need ulnar superficialis slip resection may benefit from hand therapy [34].

Anatomy & Pathophysiology

Demographics and Epidemiology

  • Trigger finger occurs in 2% to 3% of the general population [24].
  • Women are more commonly affected than men [24].
  • The condition is most common in women older than 50 years of age [21, 22].
  • Middle and ring finger involvement is most common in adults [21, 22].
  • The digits are affected in the following order of decreasing prevalence: thumb, ring, long, little, and index [24].
  • Trigger finger is more common in patients with systemic diseases such as diabetes mellitus (10% to 20% lifetime incidence), hypothyroidism, sarcoidosis, rheumatoid arthritis, and septic tenosynovitis [24].
  • Stenosing tenosynovitis is more common in diabetic patients than in nondiabetic patients [23].
  • When multiple digits are involved, the possibility of diabetes should be considered [23].
  • Trigger finger is associated with diabetes and inflammatory arthropathy [21, 22].
  • A clear difference exists between trigger thumbs and trigger fingers, with thumbs being more frequently affected [6].

Etiology and Pathogenesis

  • The precise etiology of trigger finger has not been elucidated [127].
  • Repetitive finger movements and local trauma are proposed causes of trigger finger [127].
  • Stress and degenerative force account for an increased incidence of trigger finger in the dominant hand [127].
  • Trigger finger is possibly associated with repetitive grasping activities [21, 22].
  • The causes of trigger finger are multiple and in each individual often multifactorial [127].
  • In patients with gout, monosodium urate precipitation elicits a fulminant inflammatory reaction in the tenosynovium [24].
  • In patients with calcific tendinitis, calcium salt deposition in the tenosynovium can result in triggering [24].
  • In patients with pseudogout, calcium pyrophosphate dihydrate crystal deposition is often localized to the triangular fibrocartilage or within the carpal tunnel [24].
  • In patients with amyloidosis, beta-2-microglobulin deposits in thick, plaque-like accumulations along the flexor tendons [24].
  • Amyloidosis is most commonly seen in patients with renal failure who are undergoing peritoneal dialysis or hemodialysis [24].
  • Trigger thumb in adults is a distinctly separate entity from “congenital” trigger thumb [36].
  • Stenosing tenosynovitis leading to inability to extend the flexed digit or flex the extended digit often produces a palpable “triggering” and usually is seen in individuals older than 45 years of age [36].
  • When associated with a collagen disease, several fingers may be involved, most often the long and ring fingers [36].
  • Trigger finger is an atraumatic medical phenomenon [5].

Histology and Pathology

  • Histology of trigger finger shows fibrocartilaginous metaplasia of the pulley and/or FDS tendon [21, 22].
  • Pathologic examination of the affected pulleys demonstrates a proliferation of chondrocytes and increased type III collagen [24].
  • The flexor digitorum profundus tendon will often demonstrate a pathologic nodule, while the flexor digitorum superficialis is often unaffected [24].
  • The lump in the palm may be the thickened area in the first annular pulley or a nodule or fusiform swelling of the flexor tendon just distal to it [36].
  • The tendon nodule usually is just proximal to the anulus at the metacarpophalangeal joint level [36].
  • In a rheumatoid patient, a nodule distal to the metacarpophalangeal joint level may cause triggering [36].
  • In trigger digits, fragmentation of the gliding surface of the A1 pulley is probably a result of anomalous friction forces during flexion-extension movements [136].
  • Congenital trigger digit involves narrowing and thickening of the sheath, with occasional formation of a ganglion cyst [123].
  • An intratendinous nodule may be present proximal to the first annular pulley in congenital trigger digit, often referred to as Notta’s nodule [123].
  • Chronic inflammation is frequent in congenital trigger digit [123].

Clinical Presentation and Classification

  • Trigger finger is characterized by pain and tenderness in the palm at the proximal edge of the digital A1 pulley [23].
  • Patients frequently note catching or triggering of the affected finger or thumb after forceful flexion [23].
  • In more severe cases, the opposite hand must be used to force the finger or thumb passively into extension [23].
  • In the most severe cases, the finger becomes locked in a flexed position [23].
  • Triggering is often more pronounced in the morning than later in the day [23].
  • Pain and tenderness in the distal palm progress to mechanical catching/locking, and may become fixed [21, 22].
  • A common complaint is referred pain at the dorsal MCP/PIP area [21, 22].
  • Concomitant trigger finger and carpal tunnel syndrome occurs in 40% to 60% of patients [21, 22].
  • Physical examination findings may include tenderness to palpation of the flexor tendon at the level of the A1 pulley [24].
  • Physical examination findings may include palpable triggering/pain with flexion and extension of the finger [24].
  • Physical examination findings may include nodularity of the flexor tendon just proximal to the A1 pulley [24].
  • Physical examination findings may include the presence of a volar retinacular ganglion cyst between the A1 and A2 pulleys [24].
  • Physical examination findings may include the presence of a fixed flexion deformity of the proximal interphalangeal (PIP) joint [24].
  • Green classification Grade I is defined as pain over the A1 pulley [21, 22, 24].
  • Green classification Grade II is defined as mechanical catching of the digit without locking [21, 22, 24].
  • Green classification Grade III is defined as mechanical locking of the digit which is passively correctable [21, 22, 24].
  • Green classification Grade IV is defined as a fixed locked finger [21, 22, 24].
  • Patients may experience triggering after operative release because of catching of the tendon on the palmar aponeurosis transverse fibers [36].
  • Triggering after operative release due to palmar aponeurosis catching usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the metacarpophalangeal level heals with a nodule sufficiently large to cause triggering [36].
  • Local tenderness may be present but is not a prominent complaint in trigger finger [36].
  • Pressure accentuates the apparent snapping or triggering of the more distal joints [36].
  • Patients frequently state that the problem is in the proximal interphalangeal joint with trigger finger or in the proximal interphalangeal joint with trigger thumb [36].
  • Other conditions, such as intraarticular disorders and common extensor tendon subluxation, can cause similar symptoms and must be considered to determine effective treatment for idiopathic trigger finger [36].
  • Trigger finger is a very common condition in which a finger gets stuck at the level of the palm [69].
  • The finger may click, catch, or may not bend completely to the palm [69].

Anatomical Variations and Associations

  • Newer evidence has found a fourth pulley (variable annular pulley) in 75% of patients with trigger thumb, which may contribute to stenosis [21, 22].
  • Anatomical studies have identified two annular and one oblique pulley in the thumb [109].
  • A clear distinction should always be made between “trigger wrist” and “trigger finger at the wrist” [30].
  • Trigger finger at the wrist can be caused by an anomalous flexor digitorum superficialis muscle belly within the carpal tunnel [30].
  • Patients with greater volar migration of the flexor tendons after carpal tunnel release are at a higher risk of developing trigger finger [145].
  • A relationship between carpal tunnel release and trigger finger is possible, related to anatomy and biomechanics modifications after CTR (e.g. possible volar migration of the flexor tendons) and/or to a coexisting disorder [99].
  • The incidence of concurrent Dupuytren’s disease and trigger finger was observed in 16% of trigger finger cases [119].
  • When considering middle and ring fingers only, Dupuytren’s disease and trigger finger were present in 25% of cases [119].
  • If three additional cases were included where Dupuytren’s disease developed within 1 year after surgery for trigger finger, the incidence would be 28% [119].
  • The percentage of patients with combined trigger finger and Dupuytren’s disease strongly increases with age [83].
  • 50% of patients in the “80+” age group with trigger finger are suffering from both diseases [83].
  • Smith considers trigger finger as an early indication of Dupuytren’s disease [135].
  • In the extended finger position, thickening of the pulley wall leads to narrowing of the A1 pulley and synovial congestion [135].
  • The additional mechanical irritation of the Dupuytren’s cord above the A1 pulley may provoke an aggravation of the irritation [135].
  • In more progressed stages of Dupuytren’s contracture (Stages II or III), the concomitant appearance of trigger finger and Dupuytren’s contracture is rarely seen [135].
  • Advanced extension deficit reduces the range of motion of the tendon and thus causes less mechanical irritation at A1 [135].
  • The tendon becomes slightly thinner distal to the chiasm of the deep and superficial flexor tendon [135].

Pediatric Anatomy and Pathophysiology

  • Congenital trigger digit occurs when the normal gliding movement of the flexor tendon is impeded within the digital flexor sheath [123].
  • In contrast to the situation in adults with stenosing tenosynovitis, the congenitally involved finger usually shows a persistent flexion deformity, rather than actual "triggering" [123].
  • Congenital trigger digit is a relatively rare condition (2.3%) [123].
  • Congenital trigger digit occurs far more commonly in the thumb and is bilateral in about 25% of patients [123].
  • The condition occurs sporadically and is not believed to be an inherited trait [123].
  • Trigger digits typically occur without other anomalies, but an association with trisomy 13 has been reported [123].
  • An association with mucopolysaccharidosis has also been described [123].
  • Trigger digits in children are more commonly acquired; 25% are noted at birth [123].
  • A prospective study of 5765 newborns did not reveal a single case of congenital trigger thumb [123].
  • The condition is frequently not noted until age 1 or 2 years, at which time the child has a relatively fixed flexion posture of the interphalangeal joint of the thumb [123].
  • Even with some force, it may be impossible to extend the interphalangeal joint of the thumb fully [123].
  • The abnormal clicking or snapping usually is not the presenting complaint as seen in adults [123].
  • This condition must be differentiated from the clasped thumb deformity, in which there is primarily metacarpophalangeal flexion [123].
  • Fixed contractures are unlikely if the condition resolves or is corrected before the child is 3 years old [123].
  • Spontaneous resolution occurs in about 30% of children in whom the condition appears within the first year of life [123].
  • Spontaneous resolution occurs in about 12% of children in whom it appears between 6 months and 2 years of age [123].
  • Baek et al. noted spontaneous resolution in 63% over a median of 48 months [123].
  • Trigger finger is not often associated with a fixed flexion deformity in children [123].
  • Trigger finger in children may not respond to a simple A-pulley release [123].
  • When surgical intervention for pediatric trigger finger is undertaken, the surgeon should be prepared for a more extensive exploration of the flexor mechanism, which may include excision of one or both slips of the flexor digitorum superficialis tendon and release of the A3 pulley [123].
  • In children, trigger finger is distinctly different from trigger thumb, being rarer and not often associated with a fixed flexion contracture [146].
  • None of the congenital trigger thumbs resolved spontaneously, whereas two trigger fingers recovered without operation [6].

Classification

  • The Green classification system categorizes trigger finger into four grades based on clinical presentation [21].
  • Grade I trigger finger is defined as pain and tenderness at the A1 pulley [21].
  • Grade II trigger finger is defined as catching of the finger [21].
  • Grade III trigger finger is defined as locking of the finger that is passively correctable [21].
  • Grade IV trigger finger is defined as a fixed, locked finger [21].
  • The Quinnel grading system includes grades I, II, III, and IV for trigger finger [129].
  • The modified Green classification includes grades 0, 1, 2, and 3 for triggering [64].
  • In a study of 302 fingers, 12% were classified as grade I, 13% as grade II, and 75% as grade III [47].
  • There was no statistically significant difference between Green grades I, II, and III regarding the percentage of fingers successfully treated with injection [47].
  • In a study of 90 trigger digits, severity was graded according to Green's classification, with Grade I and II grouped as mild triggering and Grade III and IV grouped as severe triggering [63].
  • The Quinnel classification is used to assess trigger finger severity in the context of ultrasound-guided acupotomy [134].
  • Two distinct clinical types of trigger digits exist: nodular and diffuse [104].

Clinical Presentation

  • Trigger finger is defined as stenosing tenosynovitis of the flexor tendons with mechanical impingement of the flexor tendons at the A1 pulley [24].
  • Women are more commonly affected by trigger finger than men [24].
  • Trigger finger is more common in patients with systemic diseases such as diabetes mellitus, hypothyroidism, sarcoidosis, rheumatoid arthritis, and septic tenosynovitis [24].
  • Gout can present with marked pain, erythema, swelling, and warmth that mimics infectious tenosynovitis [24].
  • Calcific tendinitis can result in triggering and is affected five times more frequently in males than females [24].
  • Pseudogout involves calcium pyrophosphate dihydrate crystal deposition often localized to the triangular fibrocartilage or within the carpal tunnel [24].
  • Amyloidosis is characterized by the deposition of beta-2-microglobulin in thick, plaque-like accumulations along the flexor tendons and is most commonly seen in patients with renal failure undergoing dialysis [24].
  • Physical examination findings may include palpable triggering or pain with flexion and extension of the finger [24].
  • A clinical diagnosis of trigger finger is defined as a history of triggering or locking of a finger with or without pain and tenderness or swelling at the A1 pulley [61].
  • Patients may note a lump or knot in the palm, which may be the thickened area in the first annular pulley or a nodule or fusiform swelling of the flexor tendon just distal to it [36].
  • The tendon nodule can be palpated by the examiner’s fingertip and moves with the tendon [36].
  • Patients may experience triggering after operative release because of catching of the tendon on the palmar aponeurosis transverse fibers, which usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the metacarpophalangeal joint level heals with a nodule sufficiently large to cause triggering [36].
  • Local tenderness may be present but is not a prominent complaint [36].
  • Pediatric trigger finger is a distinct ailment from adult trigger finger, and a secondary cause must be sought whenever long fingers are affected [55].
  • Acute trigger finger caused by partial flexor tendon injury is an uncommon but well-documented presentation [58].
  • Ultrasonography can detect various lesions in clinical trigger fingers, and some ultrasonographic findings correlated with clinical findings [59].

Investigations

Clinical Assessment and Classification

  • Pain and tenderness at the A1 pulley characterizes Grade I trigger finger [21, 22].
  • Mechanical catching of the digit without locking characterizes Grade II trigger finger [21, 22].
  • Mechanical locking of the digit which is passively correctable characterizes Grade III trigger finger [21, 22].
  • A fixed locked finger characterizes Grade IV trigger finger [21, 22].
  • Tenderness to palpation of the flexor tendon at the level of the A1 pulley is a physical examination finding [24].
  • Palpable triggering or pain with flexion and extension of the finger is a physical examination finding [24].
  • Nodularity of the flexor tendon just proximal to the A1 pulley is a physical examination finding [24].
  • The presence of a volar retinacular ganglion cyst between the A1 and A2 pulleys is a physical examination finding [24].
  • The presence of a fixed flexion deformity of the proximal interphalangeal (PIP) joint is a physical examination finding [24].
  • Observing the triggering of the digit guides the patient's treatment and assists in diagnosing trigger finger [39].

Imaging

  • Thickening and hypervascularization of the A1 pulley are the hallmarks of trigger fingers on sonography [130].
  • Ultrasound can detect various lesions in clinical trigger fingers, and some ultrasound findings correlated with clinical findings [59].
  • Advanced imaging is critical for identifying bony prominences causing locking when common etiologies are absent [120].

Treatment

Non-Operative Management

  • Corticosteroid injections are effective in 57% of patients with trigger finger [8].
  • A single corticosteroid injection for trigger finger has a 45% long-term success rate [31].
  • Steroid injections were an effective first-line intervention for the treatment of trigger finger [43].
  • The current evidence supports the use of corticosteroid injection as a first-line treatment for trigger finger [67].
  • A prospective, controlled, double-blind trial showed that steroid injection is a satisfactory treatment for trigger finger in 60% of patients [88].
  • Thirty-nine percent of second and third corticosteroid injections for trigger finger yield long-term relief [46].
  • Trigger finger patients with metabolic syndrome are at risk of poorer functional outcomes and treatment failure after a single corticosteroid injection than age- and sex-matched controls [11].
  • Diabetic patients are generally less responsive to corticosteroid injection for trigger finger [21, 22].
  • There is no difference between soluble and insoluble corticosteroid preparations for the treatment of trigger finger [21, 22].
  • Splinting is an effective short-term conservative treatment for trigger finger, offering symptom relief and functional improvement comparable to corticosteroid injections [45].
  • Orthoses are effective for non-surgical management of pediatric and adult trigger finger using various orthotic options [89].
  • Initiating conservative treatment with the MCP joint blocking splint has value for patients with trigger finger and positive outcomes in 77% of subjects, whereas use of the DIP joint splint was effective in about half of subjects [87].
  • A randomized clinical trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments [60].
  • The use of an injection without lidocaine is recommended to treat trigger finger [86].

Operative Management

  • Open surgical release of the A1 pulley effectively alleviates the subjective and objective manifestations of trigger finger and remains the benchmark procedure [91].
  • Surgical release of the A1 pulley provides satisfactory results in >90% of patients [24].
  • Approximately 97% of patients have complete resolution after operative treatment for trigger finger [36].
  • Open release is an effective treatment for trigger finger with limited need for nonprescription drugs, since almost all patients reported full resolution of triggering within 6 weeks, and analgesic use was minimal [74].
  • A study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography [15].
  • While the clinical significance of findings regarding ultrasound-assisted percutaneous release is unclear, it raises questions regarding the safety and efficacy of percutaneous trigger finger release, even when adding ultrasound guidance [7].
  • In patients with rheumatoid arthritis, the preference is to excise a slip of the FDS tendon rather than to release the A1 pulley, because these patients are at risk for ulnar drift at the MCP joint [21, 22].
  • The radial digital nerve is at risk of iatrogenic injury during thumb trigger finger release, given its superficial location [21, 22].
  • Minor complications of open trigger finger release include wound dehiscence, scar tenderness, and decreased range of motion [21, 22].
  • Management of diabetic trigger finger with immediate surgical release in the clinic is the most cost-effective treatment strategy, assuming a corticosteroid injection failure rate of at least 34% [90].
  • The incidence and treatment outcome of cases in which trigger finger occurred in conjunction with Dupuytren's disease appeared less predictable than that of ordinary trigger finger [48].

Complications

Open Surgical Release

  • Major complications following trigger finger release are unlikely; however, minor complications are prominent [71].
  • About 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger [72].
  • About 1 in 200 fingers have a second surgery after surgical release of the A1 pulley for idiopathic trigger finger [72].
  • Incomplete pulley release and damage to the flexor tendons and digital nerves, especially in the index finger and thumb, remain of some concern with limited exposure techniques [36].
  • The recurrence rate for surgical treatment of trigger finger was 3%, with only a single patient requiring reoperation in a long-term follow-up study [76].
  • No nerve injuries, tendon bowstringing, or ulnar deviation of the digits were observed in a long-term follow-up study of surgical treatment for trigger finger [76].
  • There were no wound infections in a long-term follow-up study of surgical treatment for trigger finger [76].
  • Open surgery for trigger finger and trigger thumb has been associated with excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing [49].
  • In patients with rheumatoid arthritis, release of the A1 pulley carries a chance that ulnar drift at the MCP joint can be exacerbated [21].
  • Triggering after operative release can occur because of catching of the tendon on the palmar aponeurosis transverse fibers, which usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the A1 pulley level heals with a nodule sufficiently large to cause triggering [36].
  • Proximal interphalangeal joint pain in trigger finger patients results from long symptom duration and consequent joint pathology, and is incompletely resolved after A1 pulley release, leading to worse surgical outcomes than expected [25].
  • Physicians should consider the duration of preoperative symptoms and preoperative flexion contracture of the PIP joint when deciding timing of surgery for trigger finger patients [28].
  • Patients with more lifetime trigger fingers and/or prior trigger finger releases for other fingers are more likely to need ulnar superficialis slip resection [34].
  • Overall, 2.9% of patients underwent subsequent treatment in the same digit after initial trigger finger release [112].
  • Overall, 37.3% of patients underwent subsequent treatment in another digit after initial trigger finger release [112].
  • Smoking and higher comorbidity were independently associated with subsequent treatment in an additional finger after initial trigger finger release [112].
  • Patients with a higher BMI were less likely to require subsequent treatment in the digit initially released [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 16% experienced a complication [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 7% experienced a complication requiring either antibiotics, further steroid injection, or pharmacologic treatments [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 2.2% required some form of surgical intervention [112].
  • In a study of 795 digits released, the incidence of reoperation was 2.4% [112].
  • There were no significant differences in scar quality or improvement in patient-reported disability with transverse or longitudinal incisions for trigger finger release [70].

Percutaneous Release

  • Trigger digits were successfully treated in 100% of the cases using the percutaneous technique in a prospective randomized trial [116].
  • A greater risk of lesion to the neurovascular sheath exists with the percutaneous release of the thumb and small finger [81].

Corticosteroid Injection

  • Corticosteroid injections may elevate serum glucose levels for 5 days or more in patients with diabetes mellitus [36].
  • Preoperative hypoglycemia increased infection risk after trigger finger injection and release [19].
  • There were no complications from injection and no patient was made worse in a study of 302 fingers treated with steroid injection [47].

Combined Pathologies

  • In cases of trigger finger combined with Dupuytren's disease where Dupuytren's tissue was resected, 58% developed a recurrence with induration in the operated area within 1 year [54].
  • Patients with trigger finger combined with Dupuytren's disease who underwent resection of Dupuytren's tissue reported problems in flexion of the fingers with permanent tension in the finger as a result of ongoing irritation reactions for months after the operation [54].

Recovery

Non-Operative Recovery

  • A single corticosteroid injection for trigger finger has a 45% long-term success rate, with success beyond two years likely predicting lasting symptom relief [31].
  • Although symptomatic resolution of trigger finger from a single corticosteroid injection can occur early on, a followup of 4 weeks (28 days) does not allow enough time for symptom resolution [27].
  • A dose-response characteristic was demonstrated in the treatment of trigger finger with triamcinolone acetonide [153].
  • Patients with marked triggering, symptoms of more than 6 months' duration, and multiple involved digits had a higher rate of failure in both groups [154].

Operative Recovery

  • This large retrospective series suggests that about 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger and that about 1 in 200 have a second surgery [72].
  • Percutaneous A1 pulley release is more effective medium-term therapy for trigger digit than steroid injection, because of lower risk of recurrence [75].
  • Simultaneous steroid injection at the time of surgical release provides greater subjective improvement in the early period after percutaneous trigger finger release [148].
  • Symptom relief period after open A1 pulley release for trigger fingers was positively correlated with preoperative symptom duration and number of preoperative corticosteroid injections [152].
  • Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need USSR, and these patients may benefit from hand therapy [34].

Key Evidence

  • [L4] Female patients presenting with their first trigger finger have the highest rate of long-term treatment success after a single corticosteroid injection. [1] (10.2106/jbjs.n.00004)
  • [L3] Open trigger finger release is generally a low-risk procedure, although there is potential for complications, some requiring reoperation. [2] (10.1007/s11552-014-9716-9)
  • [L3] This technique should be the treatment of choice for the established trigger finger with symptoms of more than 4 months' duration. [3] (10.1016/0363-5023(92)90125-9)
  • [L3] Factors associated with a worse outcome following a steroid injection were identified and should be considered when choosing the treatment of a trigger finger. [4] (10.1302/0301-620x.104b10.bjj-2022-0058.r3)
  • [L5] Surgical open release is the “gold standard” of trigger finger treatment because it allows more careful inspection of the surgical area and is highly effective with low complication rates. [5] (10.1142/s021881041750023x)
  • [L4] A clear difference exists between trigger thumbs and trigger fingers, with thumbs being more frequently affected and none resolving spontaneously, whereas two trigger fingers recovered without operation. [6] (10.1016/s0363-5023(96)80213-9)
  • [L5] While the clinical significance of these findings is unclear, it raises questions regarding the safety and efficacy of percutaneous trigger finger release, even when adding ultrasound guidance. [7] (10.1007/s11552-008-9137-8)
  • [L1] Corticosteroid injections are effective in 57% of patients with trigger finger. [8] (10.5435/00124635-200703000-00006)
  • [Paper] Patients' preferences for trigger finger treatment often change after consulting with a hand surgeon and during treatment, but these choices do not affect treatment satisfaction. [9] (10.1007/s12593-015-0203-5)
  • [L3] Trigger finger patients with metabolic syndrome are at risk of poorer functional outcomes and treatment failure after a single corticosteroid injection than age- and sex-matched controls. [11] (10.1016/j.jhsa.2016.07.091)
  • [L4] These data suggest that surgical management may be the next best option in patients with trigger finger who continue to be symptomatic after a single injection. [12] (10.1016/s0363-5023(05)80194-7)
  • [L5] Based on our findings, percutaneous trigger finger release can safely be performed on all digits, including the thumb, small fingers, and index fingers. [13] (10.1007/s11552-007-9069-8)
  • [L2] Management of trigger finger with 2 steroid injections before surgery is the least costly treatment strategy. [14] (10.1016/j.jhsa.2009.02.029)
  • [L4] The study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography. [15] (10.1177/1753193413517992)
  • [L4] Surgical release can be recommended as an adequate treatment with minimal morbidity for any grade of trigger finger or thumb with failed non-operative treatment and for severe (Grade IV) trigger digits. [16] (10.1016/j.jhsb.2007.02.016)
  • [L4] Patients who undergo open trigger finger release surgery in the clinic have complication rates similar to reported complication rates of surgery performed in the operating room. [17] (10.1016/j.jhsg.2022.01.008)
  • [L3] Percutaneous release is permanent, safe, and cost-effective and should be considered as first-line treatment for demonstrable trigger fingers. [18] (10.5435/jaaosglobal-d-25-00445)
  • [L4] Proximal interphalangeal joint pain in trigger finger patients results from long symptom duration and consequent joint pathology, and is incompletely resolved after A1 pulley release, leading to worse surgical outcomes than expected. [25] (10.1177/1753193418809771)
  • [L3] Although symptomatic resolution of trigger finger from a single corticosteroid injection can occur early on, a followup of 4 weeks (28 days) does not allow enough time for symptom resolution. [27] (10.1142/s2424835518500364)
  • [L4] Physicians should consider the duration of preoperative symptoms and preoperative flexion contracture of the PIP joint when deciding timing of surgery for trigger finger patients. [28] (10.1016/j.jhsa.2018.06.023)
  • [L5] A clear distinction should always be made between “trigger wrist” and “trigger finger at the wrist”. [30] (10.1016/j.main.2007.08.004)
  • [L5] This commentary highlights that a single corticosteroid injection for trigger finger has a 45% long-term success rate, with success beyond two years likely predicting lasting symptom relief, though results vary by sex and number of affected digits. [31] (10.2106/jbjs.n.00832)
  • [L2] Repeated corticosteroid injections for recurrent trigger finger should be considered in patients who prefer nonsurgical treatment, especially in those without factors predictive of failure. [33] (10.1016/j.jhsa.2023.12.002)
  • [L3] Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need USSR, and these patients may benefit from hand therapy. [34] (10.1016/j.jhsa.2024.08.013)
  • [L4] Observing the triggering of the digit guides the patient's treatment, and the outlined technique assists in diagnosing and treating one of the most common hand conditions seen in practice. [39] (10.1016/j.jhsa.2011.12.014)
  • [L4] Steroid injections were an effective first-line intervention for the treatment of trigger finger. [43] (10.1016/j.jhsa.2014.09.006)
  • [L4] Comparing patients and hand surgeons, there were some differences in treatment preferences and perceived advantages and disadvantages regarding idiopathic trigger finger—differences that might be addressed by a decision aid. [44] (10.1016/j.jhsa.2014.08.010)
  • [L2] Splinting is an effective short-term conservative treatment for trigger finger, offering symptom relief and functional improvement comparable to corticosteroid injections. [45] (10.1016/j.jhsg.2025.100881)
  • [L4] Thirty-nine percent of second and third corticosteroid injections for trigger finger yield long-term relief. [46] (10.1016/j.jhsa.2017.02.001)
  • [L4] [47] (10.1016/0363-5023(90)90149-l)
  • [Textbook] The incidence and treatment outcome of cases in which trigger finger occurred in conjunction with Dupuytren's disease appeared less predictable than that of ordinary trigger finger. [48] (10.1007/978-3-642-22697-7_31)
  • [L4] The authors recommend open surgery for trigger finger and trigger thumb, citing excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing. [49] (10.1007/s00402-008-0802-8)
  • [L4] Pediatric trigger finger is a distinct ailment from adult trigger finger, and a secondary cause must be sought whenever long fingers are affected. [55] (10.1177/1558944715627634)
  • [L4] Acute trigger finger caused by partial flexor tendon injury is an uncommon but well-documented presentation. [58] (10.1177/1558944716681950)
  • [L4] US can detect various lesions in clinical trigger fingers, and some US findings correlated with clinical findings. [59] (10.1007/s00296-009-1165-3)
  • [L5] The author notes that the referenced trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments, leading the trial authors to recommend splinting alone as the least invasive option. [60] (10.1097/corr.0000000000002726)
  • [L1] [61] (10.1136/ard.2007.073106)
  • [L2] Offering up to three corticosteroid injections before surgical release represents the most cost-effective contemporary strategy for trigger finger management from a current Medicare payer perspective. [62] (10.1016/j.jhsg.2026.101103)
  • [L4] [63] (10.4055/cios.2012.4.4.263)
  • [L4] [64] (10.1016/j.hansur.2016.02.004)
  • [L4] The current evidence supports the use of corticosteroid injection as a first-line treatment for trigger finger. [67] (10.1177/175899830701200304)
  • [L1] [69] (10.1177/15589447211058816)
  • [L2] There were no significant differences in scar quality or improvement in patient-reported disability with transverse or longitudinal incisions for trigger finger release. [70] (10.1177/1753193419859375)
  • [L3] Major complications following trigger finger release are unlikely; however, minor complications are prominent. [71] (10.1177/15589447221081869)
  • [L4] This large retrospective series suggests that about 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger and that about 1 in 200 have a second surgery. [72] (10.1016/j.jhsa.2012.05.014)
  • [L4] The study demonstrates that procedure room-based treatment of trigger finger is less costly than release in the OR. [73] (10.1097/gox.0000000000002509)
  • [L2] Open release is an effective treatment for trigger finger with limited need for nonprescription drugs, since almost all patients reported full resolution of triggering within 6 weeks, and analgesic use was minimal. [74] (10.1016/j.jhsa.2025.12.006)
  • [L1] Percutaneous A1 pulley release is more effective medium-term therapy for trigger digit than steroid injection, because of lower risk of recurrence. [75] (10.1177/1753193410381824)
  • [L4] [76] (10.1016/s0363-5023(05)80195-9)
  • [L1] [81] (10.1093/rheumatology/ker315)
  • [L1] We recommend the use of an injection without lidocaine to treat trigger finger. [86] (10.1016/j.jhsa.2018.06.090)
  • [L1] Initiating conservative treatment with the MCP joint blocking splint has value for patients with trigger finger and positive outcomes in 77% of subjects, whereas use of the DIP joint splint was effective in about half of subjects. [87] (10.1016/j.jhsa.2011.10.038)
  • [L1] Our prospective, controlled, double-blind trial showed that steroid injection is a satisfactory treatment for trigger finger in 60% of patients. [88] (10.1016/0266-7681(92)90014-s)
  • [L1] Orthoses are effective for non-surgical management of pediatric and adult trigger finger using various orthotic options. [89] (10.1016/j.jht.2023.05.016)
  • [L3] Management of diabetic trigger finger with immediate surgical release in the clinic is the most cost-effective treatment strategy, assuming a corticosteroid injection failure rate of at least 34%. [90] (10.1016/j.jhsa.2016.08.007)
  • [L5] Open surgical release of the A1 pulley effectively alleviates the subjective and objective manifestations of trigger finger and remains the benchmark procedure. [91] (10.5435/jaaos-d-19-00614)
  • [L1] Because of lower costs and quicker procedure with equal functional outcome when compared with open surgery, we recommend the percutaneous technique using a L15 blade for trigger finger release. [97] (10.1097/bth.0b013e31817f289a)
  • [L4] However, a relationship is possible, related to anatomy and biomechanics modifications after CTR (e.g. possible volar migration of the flexor tendons) and/or to a coexisting disorder (with the same etiology). [99] (10.1016/j.main.2015.03.003)
  • [L3] Two distinct clinical types of trigger digits exist—nodular and diffuse. [104] (10.1016/s0363-5023(89)80024-3)
  • [L5] Anatomical studies have identified two annular and one oblique pulley in the thumb. [109] (10.1016/s0363-5023(77)80101-9)
  • [L4] [112] (10.1016/j.jhsa.2025.02.009)
  • [L1] Trigger digits were successfully treated in 98% of the cases using the open surgical technique and in 100% of the cases using the percutaneous technique. [116] (10.1053/jhsu.2001.24967)
  • [L4] This case supports the inclusion of metacarpal head osteochondroma in the differential diagnosis of a 'trigger finger.' Advanced imaging is critical for identifying bony prominences causing locking when common etiologies are absent. [120] (10.1016/j.jhsg.2023.03.010)
  • [L5] [127] (10.1007/s12178-007-9012-1)
  • [L3] [129] (10.1097/bth.0000000000000231)
  • [L4] Thickening and hypervascularization of the A1 pulley are the hallmarks of trigger fingers on sonography. [130] (10.7863/jum.2008.27.10.1407)
  • [L1] [134] (10.1186/s13018-023-04127-3)
  • [L4] In the trigger digits, this fragmentation of the gliding surface is, probably, a result of anomalous friction forces during flexion-extension movements of the fingers between the pulley and the flexor tendons. [136] (10.1016/j.jhsb.2007.01.013)
  • [L3] Patients with greater volar migration of the flexor tendons after CTR are at a higher risk of developing trigger finger. [145] (10.1177/1753193413479506)
  • [L4] In children, trigger finger is distinctly different from trigger thumb, being rarer and not often associated with a fixed flexion contracture. [146] (10.1053/jhsu.1999.1156)
  • [L1] Simultaneous steroid injection at the time of surgical release provides greater subjective improvement in the early period after percutaneous trigger finger release. [148] (10.1177/1753193418813771)
  • [L4] Symptom relief period after open A1 pulley release for trigger fingers was positively correlated with preoperative symptom duration and number of preoperative corticosteroid injections. [152] (10.1016/j.jhsa.2017.06.087)
  • [L1] A dose-response characteristic was demonstrated in the treatment of trigger finger with triamcinolone acetonide. [153] (10.1142/s2424835518500157)
  • [L4] Patients with marked triggering, symptoms of more than 6 months' duration, and multiple involved digits had a higher rate of failure in both groups. [154] (10.1016/0363-5023(92)90124-8)

References

[1] Long-Term Outcomes Following a Single Corticosteroid Injection for Trigger Finger. Journal of Bone and Joint Surgery. 2014. DOI: 10.2106/jbjs.n.00004

[2] Risk Factors for Complications of Open Trigger Finger Release. HAND. 2014. DOI: 10.1007/s11552-014-9716-9

[3] Percutaneous release of the trigger finger: An office procedure. The Journal of Hand Surgery. 1992. DOI: 10.1016/0363-5023(92)90125-9

[4] Factors associated with conversion to surgical release after a steroid injection in patients with a trigger finger. The Bone & Joint Journal. 2022. DOI: 10.1302/0301-620x.104b10.bjj-2022-0058.r3

[5] Trigger Finger: An Atraumatic Medical Phenomenon. The Journal of Hand Surgery (Asian-Pacific Volume). 2017. DOI: 10.1142/s021881041750023x

[6] Congenital trigger digit. The Journal of Hand Surgery. 1996. DOI: 10.1016/s0363-5023(96)80213-9

[7] Ultrasound-Assisted Percutaneous Trigger Finger Release: Is it Safe?. HAND. 2008. DOI: 10.1007/s11552-008-9137-8

[8] Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review. Journal of the American Academy of Orthopaedic Surgeons. 2007. DOI: 10.5435/00124635-200703000-00006

[9] Early Patient Satisfaction with Different Treatment Pathways for Trigger Finger and Thumb. Journal of Hand and Microsurgery. 2015. DOI: 10.1007/s12593-015-0203-5

[11] Effect of Metabolic Syndrome on the Outcome of Corticosteroid Injection for Trigger Finger: Matched Case-Control Study. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2016.07.091

[12] Injection versus surgery in the treatment of trigger finger. The Journal of Hand Surgery. 1997. DOI: 10.1016/s0363-5023(05)80194-7

[13] The Safety of Percutaneous Trigger Finger Release. HAND. 2007. DOI: 10.1007/s11552-007-9069-8

[14] Using Evidence to Minimize the Cost of Trigger Finger Care. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.02.029

[15] A study of 60 patients with percutaneous trigger finger releases: clinical and ultrasonographic findings. Journal of Hand Surgery (European Volume). 2014. DOI: 10.1177/1753193413517992

[16] Outcome of Open Trigger Digit Release. Journal of Hand Surgery (European Volume). 2007. DOI: 10.1016/j.jhsb.2007.02.016

[17] Office-Based Open Trigger Finger Release Has a Low Complication Rate. Journal of Hand Surgery Global Online. 2022. DOI: 10.1016/j.jhsg.2022.01.008

[18] Percutaneous Release of Trigger Finger: Long-Term Review of Outcomes Using 18-Gauge Needle. JAAOS: Global Research and Reviews. 2026. DOI: 10.5435/jaaosglobal-d-25-00445

[19] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > REFERENCES > TRIGGER THUMB AND TRIGGER FINGER.

[20] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > TRIGGER FINGER AND THUMB > SURGICAL RELEASE OF TRIGGER FINGER.

[21] Miller S Review Of Orthopaedics. SECTION 16 PATELLAR TRACKING IN TOTAL KNEE ARTHROPLASTY > 2. Flexor tendon injury > 3. Stenosing tenosynovitis (trigger finger).

[22] Miller S Review Of Orthopaedics. 2. Flexor tendon injury > 3. Stenosing tenosynovitis (trigger finger).

[23] A Lange Medical Book Current Diagnosis Treatment In Orthopedics Fifth Edition. 9Hand Surgery > 2. Flexor Tenosynovitis (Trigger Finger and Trigger Thumb).

[24] Aaos Comprehensive Orthopaedic Review 3. Tendinopathy of the Hand and Wrist* > II. Trigger Finger.

[25] Clinical significance of proximal interphalangeal joint pain in patients with trigger fingers. Journal of Hand Surgery (European Volume). 2018. DOI: 10.1177/1753193418809771

[27] Establishing an Efficient Care Paradigm for Trigger Finger. The Journal of Hand Surgery (Asian-Pacific Volume). 2018. DOI: 10.1142/s2424835518500364

[28] Factors Causing Prolonged Postoperative Symptoms Despite Absence of Complications After A1 Pulley Release for Trigger Finger. The Journal of Hand Surgery. 2019. DOI: 10.1016/j.jhsa.2018.06.023

[30] “Trigger finger at the wrist” due to anomalous flexor digitorum superficialis muscle belly within the carpal tunnel. Chirurgie de la Main. 2007. DOI: 10.1016/j.main.2007.08.004

[31] Doc, Will This Injection Make My Trigger Finger Go Away?. Journal of Bone and Joint Surgery. 2014. DOI: 10.2106/jbjs.n.00832

[33] Factors Influencing the Successful Treatment of Recurrent Trigger Finger With Repeated Corticosteroid Injections: A Prospective Cohort Study. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2023.12.002

[34] Risk Factors for Requiring Ulnar Superficialis Slip Resection During Trigger Finger Release. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.08.013

[36] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > TRIGGER FINGER AND THUMB.

[39] An Observation on Trigger Fingers. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.12.014

[43] Long-Term Effectiveness of Corticosteroid Injections for Trigger Finger and Thumb. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2014.09.006

[44] Trigger Finger: Assessment of Surgeon and Patient Preferences and Priorities for Decision Making. The Journal of Hand Surgery. 2014. DOI: 10.1016/j.jhsa.2014.08.010

[45] Efficacy of Splinting in Managing Adult Trigger Finger: A Systematic Review of Short-Term Outcomes. Journal of Hand Surgery Global Online. 2026. DOI: 10.1016/j.jhsg.2025.100881

[46] Long-Term Effectiveness of Repeat Corticosteroid Injections for Trigger Finger. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.02.001

[47] Treatment of trigger finger by steroid injection. The Journal of Hand Surgery. 1990. DOI: 10.1016/0363-5023(90)90149-l

[48] 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa. Dupuytren’s Disease and Related Hyperproliferative Disorders. 2012. DOI: 10.1007/978-3-642-22697-7_31

[49] Long-term results of surgical release of trigger finger and trigger thumb in adults. Archives of Orthopaedic and Trauma Surgery. 2009. DOI: 10.1007/s00402-008-0802-8

[54] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion > 31.5.3 Surgical Strategies and Recommendations.

[55] Pediatric Trigger Finger due to Osteochondroma. HAND. 2016. DOI: 10.1177/1558944715627634

[58] Closed Partial Flexor Digitorum Profundus Rupture: An Unusual Cause of Pediatric Trigger Finger. HAND. 2016. DOI: 10.1177/1558944716681950

[59] Ultrasonographic assessment of clinically diagnosed trigger fingers. Rheumatology International. 2009. DOI: 10.1007/s00296-009-1165-3

[60] CORR Insights®: Are There Differences in Pain Reduction and Functional Improvement Among Splint Alone, Steroid Alone, and Combination for the Treatment of Adults With Trigger Finger?. Clinical Orthopaedics & Related Research. 2023. DOI: 10.1097/corr.0000000000002726

[61] Corticosteroid injections effective for trigger finger in adults in general practice: a double-blinded randomised placebo controlled trial. Annals of the Rheumatic Diseases. 2008. DOI: 10.1136/ard.2007.073106

[62] Cost-Effectiveness of Contemporary Trigger Finger Treatment Strategies: A Medicare Payer Perspective. Journal of Hand Surgery Global Online. 2027. DOI: 10.1016/j.jhsg.2026.101103

[63] The Efficacy of Steroid Injection in the Treatment of Trigger Finger. Clinics in Orthopedic Surgery. 2012. DOI: 10.4055/cios.2012.4.4.263

[64] Modified percutaneous trigger finger release. Hand Surgery and Rehabilitation. 2016. DOI: 10.1016/j.hansur.2016.02.004

[67] The Use Of Corticosteroid Injections In The Treatment Of Stenosing Tendovaginits (Trigger Finger): Three Comparative Case Studies. The British Journal of Hand Therapy. 2007. DOI: 10.1177/175899830701200304

[69] Patient Comprehension of Trigger Finger Concepts Based on Distribution Format: A Randomized Controlled Trial of Handout Versus Video. HAND. 2021. DOI: 10.1177/15589447211058816

[70] A prospective, randomized clinical trial of transverse versus longitudinal incisions for trigger finger release. Journal of Hand Surgery (European Volume). 2019. DOI: 10.1177/1753193419859375

[71] Complications Following Endoscopic and Open Trigger Finger Release: A Retrospective Comparative Study. HAND. 2022. DOI: 10.1177/15589447221081869

[72] Adverse Events of Open A1 Pulley Release for Idiopathic Trigger Finger. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2012.05.014

[73] A Cost and Efficiency Analysis of the WALANT Technique for the Management of Trigger Finger in a Procedure Room of a Major City Hospital. Plastic and Reconstructive Surgery - Global Open. 2019. DOI: 10.1097/gox.0000000000002509

[74] Patient-Reported Symptom Relief and Use of Analgesics After Open Release of Trigger Finger: A Prospective, Multicenter Cohort Study With 6 Months Follow-Up. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2025.12.006

[75] Percutaneous A1 pulley release vs steroid injection for trigger digit: the results of a prospective, randomized trial. Journal of Hand Surgery (European Volume). 2010. DOI: 10.1177/1753193410381824

[76] The results of surgical treatment of trigger finger. The Journal of Hand Surgery. 1997. DOI: 10.1016/s0363-5023(05)80195-9

[81] Treatment of trigger finger: randomized clinical trial comparing the methods of corticosteroid injection, percutaneous release and open surgery. Rheumatology. 2011. DOI: 10.1093/rheumatology/ker315

[83] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion.

[86] Trigger Finger Corticosteroid Injection With and Without Lidocaine—A Randomized, Double-Blind Controlled Trial. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2018.06.090

[87] Trigger Finger Treatment: A Comparison of 2 Splint Designs. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.10.038

[88] Controlled Study of the Use of Local Steroid Injection in the Treatment of Trigger Finger and Thumb. Journal of Hand Surgery. 1992. DOI: 10.1016/0266-7681(92)90014-s

[89] Orthotic intervention options to non-surgically manage adult and pediatric trigger finger: A systematic review. Journal of Hand Therapy. 2023. DOI: 10.1016/j.jht.2023.05.016

[90] Cost of Immediate Surgery Versus Non-operative Treatment for Trigger Finger in Diabetic Patients. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2016.08.007

[91] Current Concepts in the Management of Trigger Finger in Adults. Journal of the American Academy of Orthopaedic Surgeons. 2020. DOI: 10.5435/jaaos-d-19-00614

[97] Open Versus Percutaneous Release of the A1-Pulley for Stenosing Tendovaginitis. Techniques in Hand & Upper Extremity Surgery. 2008. DOI: 10.1097/bth.0b013e31817f289a

[99] Is carpal tunnel release associated with trigger finger?. Chirurgie de la Main. 2015. DOI: 10.1016/j.main.2015.03.003

[104] Nonoperative treatment of trigger fingers and thumbs. The Journal of Hand Surgery. 1989. DOI: 10.1016/s0363-5023(89)80024-3

[109] Anatomy of the flexor tendon sheath and pulleys of the thumb. The Journal of Hand Surgery. 1977. DOI: 10.1016/s0363-5023(77)80101-9

[112] Incidence and Predictors of Subsequent Triggering Requiring Treatment After Trigger Finger Release. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2025.02.009

[116] Prospective randomized trial of open versus percutaneous surgery for trigger digits. The Journal of Hand Surgery. 2001. DOI: 10.1053/jhsu.2001.24967

[119] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.3 Patients Characteristics and Incidence of Concurrent Disease.

[120] Metacarpal Neck Osteochondroma: An Atypical Cause of “Trigger Finger”. Journal of Hand Surgery Global Online. 2023. DOI: 10.1016/j.jhsg.2023.03.010

[123] Campbell S Operative Orthopaedics 4 Volume Set. MULTIPLE Z-PLASTY RELEASE OF A CONGENITAL RING > TRIGGER FINGERS.

[127] Trigger finger: etiology, evaluation, and treatment. Current Reviews in Musculoskeletal Medicine. 2007. DOI: 10.1007/s12178-007-9012-1

[129] Open Surgery for Trigger Finger Required Combined a1-a2 Pulley Release. A Retrospective Study on 1305 Case. Techniques in Hand & Upper Extremity Surgery. 2019. DOI: 10.1097/bth.0000000000000231

[130] Sonographic Appearance of Trigger Fingers. Journal of Ultrasound in Medicine. 2008. DOI: 10.7863/jum.2008.27.10.1407

[134] Ultrasound-guided acupotomy for trigger finger: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 2023. DOI: 10.1186/s13018-023-04127-3

[135] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion > 31.5.1 Why Is DD Concurring with TF?.

[136] Scanning Electron Microscopic Findings of the Gliding Surface of the A1 Pulley in Trigger Fingers and Thumbs. Journal of Hand Surgery (European Volume). 2007. DOI: 10.1016/j.jhsb.2007.01.013

[145] The relationship of trigger finger and flexor tendon volar migration after carpal tunnel release. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413479506

[146] Trigger finger in children. The Journal of Hand Surgery. 1999. DOI: 10.1053/jhsu.1999.1156

[148] Effects of simultaneous steroid injection after percutaneous trigger finger release: a randomized controlled trial. Journal of Hand Surgery (European Volume). 2018. DOI: 10.1177/1753193418813771

[152] Factors of Delayed Symptom Relief after A1 Pulley Release for Trigger Fingers. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.06.087

[153] Different Dosages of Triamcinolone Acetonide Injection for the Treatment of Trigger Finger and Thumb: A Randomized Controlled Trial. The Journal of Hand Surgery (Asian-Pacific Volume). 2018. DOI: 10.1142/s2424835518500157

[154] Trigger fingers and thumb: When to splint, inject, or operate. The Journal of Hand Surgery. 1992. DOI: 10.1016/0363-5023(92)90124-8

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.